REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 23rd, 2012 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 23rd, 2012 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of this October 17, 2012, is made by and between Cancer Genetics, Inc., a Delaware corporation (the “Company”), and Mark Oman (“Oman”), and John Pappajohn (“Pappajohn”) (collectively the “Investor”). The Company and the Investor are sometimes referred to herein, individually, as a “Party,” and, collectively, as the “Parties.”
CONFIDENTIAL SETTLEMENT AGREEMENT AND RELEASE OF ALL CLAIMSConfidential Settlement Agreement • October 23rd, 2012 • Cancer Genetics, Inc • Services-medical laboratories • New Jersey
Contract Type FiledOctober 23rd, 2012 Company Industry JurisdictionThis Confidential Settlement Agreement and Release (the “Agreement”) is entered into as of this th day of May, 2012 (the “Date of Execution”), between and among Louis J. Maione, Esq., Cancer Genetics, Inc (“CGI”), John Pappajohn, Raju Chaganti, Andrew Pecora, Tommy Thompson, Edmund Cannon, Matthew Kinley, Panna Sharma, and GAP Partners, LLP (“GAP”) (collectively, the “Settling Parties”).
October 15, 2012 NNJCA CAPITAL, LLCCredit Agreement • October 23rd, 2012 • Cancer Genetics, Inc • Services-medical laboratories
Contract Type FiledOctober 23rd, 2012 Company Industry
October 16, 2012 DAM Holdings, LLCCredit Agreement • October 23rd, 2012 • Cancer Genetics, Inc • Services-medical laboratories
Contract Type FiledOctober 23rd, 2012 Company Industry
October 15, 2012 Pecora and CompanyCredit Agreement • October 23rd, 2012 • Cancer Genetics, Inc • Services-medical laboratories
Contract Type FiledOctober 23rd, 2012 Company Industry
RESTATED CREDIT AGREEMENTCredit Agreement • October 23rd, 2012 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 23rd, 2012 Company Industry JurisdictionThis Restated Credit Agreement (this “Agreement”) is entered into between MARK OMAN (“Oman”) and JOHN PAPPAJOHN (“Pappajohn”) (collectively the “Lender”), and CANCER GENETICS, INC., a Delaware corporation (the “Company”), as of October 17, 2012.
AMENDMENT NO. 1 TO AFFILIATION AGREEMENTAffiliation Agreement • October 23rd, 2012 • Cancer Genetics, Inc • Services-medical laboratories • Minnesota
Contract Type FiledOctober 23rd, 2012 Company Industry JurisdictionThis Amendment No. 1 (this “Amendment”) is entered into as of September 29, 2012, by and between Cancer Genetics, Inc., a Delaware corporation (“CGI”), and Mayo Foundation for Medical Education and Research, a Minnesota nonprofit corporation (“Mayo”), amends that certain Affiliation Agreement, dated as of November 7, 2011, by and between CGI and Mayo (the “Affiliation Agreement”). To the extent not otherwise defined herein, the capitalized terms used herein shall have the meanings assigned to them in the Affiliation Agreement.